| |
| |
|
| Insider
Information: |
Jackson Michael K |
| Relationship: |
Interim CFO |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,668 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,668 |
|
|
| Total
Value |
$1 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Poniard Pharmaceuticals |
PARD |
Interim CFO |
2012-03-27 |
5,668 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2012-03-27 |
4 |
S |
$0.83 |
$214 |
D/D |
(257) |
5,668 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2012-03-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
475 |
5,925 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2012-02-16 |
4 |
S |
$0.87 |
$2,084 |
D/D |
(2,401) |
5,450 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2012-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,769 |
7,851 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2011-04-13 |
4 |
S |
$0.37 |
$2,860 |
D/D |
(7,655) |
83,312 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2011-04-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,000 |
90,967 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Interim CFO |
• – – |
2011-01-05 |
4 |
S |
$0.52 |
$23,412 |
D/D |
(44,816) |
71,967 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
105,391 |
116,783 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2010-02-08 |
4 |
S |
$1.62 |
$5,939 |
D/D |
(3,669) |
234,218 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2010-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,056 |
237,887 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2009-11-25 |
4/A |
S |
$2.23 |
$1,675 |
D/D |
(751) |
4,005 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2009-11-25 |
4 |
D |
$2.23 |
$1,675 |
D/D |
(751) |
4,005 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2009-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,854 |
4,756 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2009-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
951 |
1,902 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Principal Accounting Officer |
• – – |
2009-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
951 |
951 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Chief Accounting OfficerOffice |
• – – |
2004-04-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
300 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
